Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Burger RA; Brady MF; Bookman MA; Fleming GF; Monk BJ; Huang H; Mannel RS; Homesley HD; Fowler J; Greer BE; Boente M; Birrer MJ; Liang SX; The New England Journal Of Medicine, 2011, vol. 365, issue 26, p 2473, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation